Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Varespladib methyl | 172733-08-3 | 99.9% | 394.42 | 5 MG
SDP

Catalog No. 5000386539
Encompass_Preferred

Varespladib methyl is a selective inhibitor of group II secretory phospholipase A2 (PLA2). This orally-administered methyl ester pro-drug is metabolized to LY315920 and shows high-level secretory PLA2 (sPLA2) inhibition at nanomolar and picomolar concentrations against 28 medically important snake venoms.

  • Selective inhibitor of group II secretory phospholipase A2 (PLA2)
  • Orally-administered methyl ester pro-drug
  • Metabolized to LY315920
  • Shows high-level secretory PLA2 (sPLA2) inhibition
  • Effective against 28 medically important snake venoms

Catalog No. 50-003-86539 Supplier Medchemexpress LLC Supplier No. HY174485MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Varespladib methyl is a selective inhibitor of group II secretory phospholipase A2 (PLA2). This orally-administered methyl ester pro-drug is metabolized to LY315920 and shows high-level secretory PLA2 (sPLA2) inhibition at nanomolar and picomolar concentrations against 28 medically important snake venoms.

  • Selective inhibitor of group II secretory phospholipase A2 (PLA2)
  • Orally-administered methyl ester pro-drug
  • Metabolized to LY315920
  • Shows high-level secretory PLA2 (sPLA2) inhibition
  • Effective against 28 medically important snake venoms

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.